For the Inventor, By the Inventor

Enter assignee name

San Ramon, CA, United States of America

Bioventrix, Inc.

USPTO Granted Patents = 57

EPO Patents = 15

Trademarks = 4

Forward Citations = 1,021

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Lon S Annest (55 out of 64 patents)

Kevin H Van Bladel (25 out of 49 patents)

Sing-Fatt Chin (19 out of 26 patents)

4. Arthur A Bertolero (17 out of 70 patents)

5. Rovil Arcia (13 out of 13 patents)

6. David K Swanson (12 out of 331 patents)

7. William E Butler (11 out of 37 patents)

8. Ernie Heflin (10 out of 10 patents)

9. John Bower (10 out of 11 patents)

10. Ernest Heflin (10 out of 14 patents)

11. Murray Sheldon (8 out of 8 patents)

12. Andrew Wechsler (8 out of 8 patents)

13. John Stiggelbout (8 out of 22 patents)

14. Claudio Argento (7 out of 89 patents)

15. Meir H Moshe (6 out of 15 patents)

Core Competencies:

Heart Anchor Positioning

Congestive Heart Failure

Cardiac Tissue Penetrating

Percutaneous Left Ventricular Reconstruction

Steerable Lesion Excluding

Cardiac Implant Migration Inhibiting

Trans-Catheter Ventricular Reconstruction

Remote Pericardial Hemostasis

Tissue Protecting Devices

Location Determining Devices

Cardiac Tissue Anchoring

Over-the-Wire Cardiac Implant Delivery

57 patents: Sort by Forward Citations

1. 12582524 - Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions (2026-03-24),

2. 12533235 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions (2026-01-27),

3. 11903834 - Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions (2024-02-20),

4. 11793643 - Method and apparatus for closing off a portion of a heart ventricle (2023-10-24),

5. 11744615 - Pericardial inflation catheter and systems and methods employing same (2023-09-05),

6. 11559212 - Cardiac tissue penetrating devices, methods, and systems for treatment of congestive heart failure and other conditions (2023-01-24),

7. 11540822 - Cardiac tissue anchoring devices, methods, and systems for treatment of congestive heart failure and other conditions (2023-01-03),

8. 11529234 - Tissue protecting devices for treatment of congestive heart failure and other conditions (2022-12-20),

9. 11478353 - Percutaneous arterial access to position trans-myocardial implant devices and methods (2022-10-25),

10. 11419723 - Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states (2022-08-23),

11. 11399942 - Treating dysfunctional cardiac tissue (2022-08-02),

12. 11331190 - Steerable lesion excluding heart implants for congestive heart failure (2022-05-17),

13. 11273040 - Method and device for percutaneous left ventricular reconstruction (2022-03-15),

14. 11259929 - Method and device for treating dysfunctional cardiac tissue (2022-03-01),

15. 11185414 - Systems and methods for deploying a cardiac anchor (2021-11-30),

BioVentrix, Inc. is a medical technology company focused on developing minimally invasive therapies for the treatment of heart failure. The company's flagship product is the Revivent TC System, a non-surgical alternative for heart failure patients who are not appropriate candidates for conventional surgery. BioVentrix aims to improve patient outcomes and quality of life by providing innovative solutions for heart failure management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Bioventrix, Inc.

57 Patents

#7 in San Ramon, CA

#1,461 in California

#6,232 in US

#12,529 in the World

San Ramon, CA, United States of America

Bioventrix, Inc.

Forward Citations = 1,021

23 inventors:

Lon S Annest (55 out of 64 patents)

Kevin H Van Bladel (25 out of 49 patents)

Sing-Fatt Chin (19 out of 26 patents)

4. Arthur A Bertolero (17 out of 70 patents)

5. Rovil Arcia (13 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…